High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)-Reference-Cited by-同舟云学术

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

Published:2004-07 Issue:7 Volume:14 Page:429-440
ISSN:0960-314X
Container-title:Pharmacogenetics
language:en
Short-container-title:

Author:

Niemi Mikko,Schaeffeler Elke,Lang Thomas,Fromm Martin F,Neuvonen Mikko,Kyrklund Carl,Backman Janne T,Kerb Reinhold,Schwab Matthias,Neuvonen Pertti J,Eichelbaum Michel,Kivistö Kari T

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Reference54 articles.

1. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.;Williams;Clin Pharmacokinet,2002

2. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.;Neuvonen;Clin Pharmacol Ther,1998

3. Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects.;Singhvi;Br J Clin Pharmacol,1990

4. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter (cMOAT).;Yamazaki;Drug Metab Dispos,1997

5. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.;Konig;Biochim Biophys Acta,1999

Cited by 377 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Statin Lipophilicity on the Proliferation of Hepatocellular Carcinoma Cells;Biology;2024-06-19

2. Impact of Pharmacogenetics Markers of Human NAT2 Gene in Tuberculosis Treatment;Pharmaceutical Science;2024-05-29

3. Mechanistic Account of Distinct Change in Organic Anion Transporting Polypeptide 1B (OATP1B) Substrate Pharmacokinetics during OATP1B-Mediated Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling;Drug Metabolism and Disposition;2024-05-13

4. SLCO1B1 Genetic Variation Influence on Atorvastatin Systemic Exposure in Pediatric Hypercholesterolemia;Genes;2024-01-15

5. Relationship Between Pharmacokinetics and Pharmacogenomics, and Its Impact on Drug Choice and Dose Regimens;ADME Processes in Pharmaceutical Sciences;2024